hydrocortisone acetate 25 MG Rectal Suppository [Hemmorex]
- RxCUI
- 1674197
- RxNorm name
- hydrocortisone acetate 25 MG Rectal Suppository [Hemmorex]
- Display name
- HEMMOREX (Rectal)
- Full name
- hydrocortisone acetate 25 MG Rectal Suppository [Hemmorex]
- Term type
- SBD
- Status
- Active
- Strength
- 25 mg
- Dose form
- Suppository
- Route
- Rectal
- Updated
- 2026-10-21 00:28:26
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112015
- Active start
- 112015
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| hydrocortisone acetate | 25 MG / 1 EACH | hydrocortisone | hydrocortisone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Rectal Suppository | 316978 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| hydrocortisone | 5492 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Hemmorex 25 MG Rectal Suppository | 1 | NAMES |
| RxNorm Name | hydrocortisone acetate 25 MG Rectal Suppository [Hemmorex] | 1 | NAMES |
| RxNorm Synonym | Hemmorex 25 MG Rectal Suppository | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | db67f724-c78c-4280-9c2e-6abbaeaef42d | 1 | CODES |
| RxCUI | 1674197 | 1 | CODES |
| MMSL_CODE | BD271 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 16477-201-12 | 16477-201 | Hemmorex-HC hydrocortisone acetate | Laser Pharmaceuticals, LLC | |
| 16477-201-24 | 16477-201 | Hemmorex-HC hydrocortisone acetate | Laser Pharmaceuticals, LLC | |
| 16477-201-99 | 16477-201 | Hemmorex-HC hydrocortisone acetate | Laser Pharmaceuticals, LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemmorex-HC | HYDROCORTISONE ACETATE | Laser Pharmaceuticals, LLC | db67f724-c78c-4280-9c2e-6abbaeaef42d | 2025-01-23 | Adverse reactions | 16477-201-24 16477-201-99 16477-201-12 16477-201 16477020124 16477020112 16477020199 1674197 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| db67f724-c78c-4280-9c2e-6abbaeaef42d | HEMMOREX-HC 25 MG Rectal Suppository [PSN] · hydrocortisone acetate 25 MG Rectal Suppository [Hemmorex] [SBD] · Hemmorex 25 MG Rectal Suppository [SY] | 3 | 9 | Hemmorex-HC | 20250123 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| db67f724-c78c-4280-9c2e-6abbaeaef42d | Hemmorex-HC | Laser Pharmaceuticals, LLC | 20250123 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S02BA | Corticosteroids | ATC1-4 | hydrocortisone | |
| ATC | C05AA | Corticosteroids | ATC1-4 | hydrocortisone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | hydrocortisone | |
| ATC | A01AC | Corticosteroids for local oral treatment | ATC1-4 | hydrocortisone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | hydrocortisone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | hydrocortisone | |
| ATC | D07XA | Corticosteroids, weak, other combinations | ATC1-4 | hydrocortisone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | hydrocortisone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | hydrocortisone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | hydrocortisone |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone acetate |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | hydrocortisone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 25 MG (expressed as hydrocortisone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | HEMMOREX-HC 25 MG Rectal Suppository |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |